Model No.: CAS 288383-20-0
Productivity: 1 kg/month
Place of Origin: China
Supply Ability: 1 kg
Certificate: ISO 9001, gmp
Cediranib (AZD-2171) Introduction
Cedinib is a pan-VEGF receptor tyrosine kinase inhibitor. It mainly inhibits VEGFR-1, VEGFR-2, VEGFR-3 and PDGFR. Cetanib inhibits three vascular endothelial growth factor (VEGF) receptors, acts on blood vessels and lymphatic vessels, exerts anti-angiogenic effects, and inhibits tumor growth and spread.
[Product Name]: Cediranib (AZD-2171) powder
Cediranib (AZD2171) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.
Cediranib (AZD2171) inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 of 0.4 and 0.5 nM, respectively.
Cediranib, also known as AZD-2171, is a potent and selective VEGF inhibitor with antineoplastic activities. Competing with adenosine triphosphate, cediranib binds to and inhibits all three vascular endothelial growth factor receptor (VEGF-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth.
Boiling Point: 626.557ºC at 760 mmHg
Flash Point: 332.73ºC
Refractive Index: 1.642
Vapor Pressure: 0mmHg at 25°C
Shandong Chenyi Environmental Protection Technology Co.,Ltd
Contact Person: Jerry
Address: No.215 Beiyuan Main street,tianqiao District,Jinan,Shandong